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Background: The CHADS2 scoring system was found to be a good predictor of the risk of stroke in patients with atrial fibrillation. The effectiveness 
of this scoring system in assessing thromboembolic risk, prior to direct current cardioversion (DCC) is unknown.
Method: 3191 consecutive studies from 1999 to 2008 (mean age 66 ± 13 yrs, M: F ratio 2:1) in which transesophageal echo was performed for 
pre-DCC screening, were analyzed. Left atrial/ left atrial appendage (LA/LAA) thrombogenic milieu [Spontaneous echo contrast (SEC), sludge and 
thrombus] was investigated. The results were correlated with the CHADS2 (Congestive Heart failure, Hypertension, Age>75, Diabetes, and Stroke [2 
points]) score findings.
Results: The CHADS2 score of 0, 1, 2, 3, 4, 5 and 6 were present in 13%, 25%, 30%, 21%, 7%, 3% and 1% of the studies, respectively. The 
prevalence of LA/LAA thrombus/sludge increased with rising CHADS2 score [Score 0 (6%), 1 (8%), 2(9%), 3(10%), 4-6 (13.5%), P< 0.001]. In the 
multivariate model, ejection fraction < 25 % was the best predictor of LA/LAA sludge/thrombus (P<0.001).
Conclusions: CHADS2 scores 0 and 1 is associated with significant amount of sludge and thrombus and therefore mandates the need for revision 
for assessing thromboembolic risk prior to DCC.
